Controlling neuroinflammation in Alzheimers Disease [ 2013 - 2015 ]

Research Grant

Researchers: A/Pr Peter Crack (Principal investigator) ,  Dr Juliet Taylor ,  Prof Andrew Wilks

Brief description Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and is expected to soar to about 981,000 by 2050. AD accounts for greater than 60% of all cases of dementia. This grant investigates the role that neuroinflammation plays in the progression and exacerbation of AD and will identify new therapeutic strategies to combat this insidious disease.

Funding Amount $AUD 639,577.20

Funding Scheme Project Grants

Notes Standard Project Grant